AstraZeneca PLC ADR

Yahoo Finance • 4 hours ago

AstraZeneca (AZN) Named One of BofA’s Top 25 Stocks for 2026

AstraZeneca PLC (NASDAQ:AZN) ranks among the Best Low Volatility Investments in December 2025. BofA Securities maintained its Buy rating on AstraZeneca PLC (NASDAQ:AZN) and increased its price target to $108.50 from $91.70 on November 25.... Full story

Yahoo Finance • 16 hours ago

Sector Update: Health Care Stocks Lower Tuesday Afternoon

Health care stocks declined Tuesday afternoon, with the NYSE Health Care Index down 0.5% and the Hea PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 18 hours ago

FDA top drugs official Pazdur retiring shortly after starting - report

[Headquarters of US Food and Drug Administration (FDA)] Grandbrothers * Less than a month after taking the role, Richard Pazdur, the director of the US FDA's Center for Drug Evaluation and Research, has turned in his resignation papers,... Full story

Yahoo Finance • 21 hours ago

Baxdrostat New Drug Application accepted under FDA Priority Review in the US for patients with hard-to-control hypertension

Submission based on positive BaxHTN Phase III trial results which demonstrated statistically significant and clinically meaningful reduction in systolic blood pressure in patients with resistant or uncontrolled hypertension If approved, b... Full story

Yahoo Finance • 21 hours ago

Pharma bosses and ministers to shape future drug pricing regime

Some of the global pharmaceutical industry's top executives are to form a new panel with the government aimed at devising a new pricing regime for key medicines. Sky News understands that Whitehall officials and ministers will invite boss... Full story

Yahoo Finance • 2 days ago

U.S., U.K. Strike Deal on Higher Drug Prices

The move marks a victory for the Trump administration’s campaign to get other countries to pay more for drugs. Continue Reading View Comments... Full story

Yahoo Finance • 2 days ago

UK and US agree zero tariff deal on pharmaceuticals

The UK has sealed a deal to give the US zero tariffs on pharmaceutical products imported into the country, in return for the NHS spending more on medicines. Import taxes on medicines and treatments will remain at 0% for three years, the U... Full story

Yahoo Finance • 2 days ago

European Association for the Study of Diabetes (EASD) Annual Meeting Highlights 2025: Advancements in GLP-1RAs for Diabetes, Cardiovascular Treatments, and Therapies for Resistant Hypertension

Company Logo Key market opportunities include. Companies like Novo Nordisk, Regeneron, AstraZeneca, and Vertex are leading innovation, presenting new avenues for treatment in metabolic and cardiovascular conditions. Dublin, Dec. 01, 2025... Full story

Yahoo Finance • 2 days ago

UK to pay 25% more for new drugs under deal with US

[Pile of different colourful pills placed next to 20 British pound banknotes.] Oleksandr Siedov An agreement in principle reached between UK and US trade negotiators will have the latter's National Health Service pay 25% higher list price... Full story

Yahoo Finance • 2 days ago

Shares of vaccine makers drop after FDA memo flags reports of child deaths

Investing.com -- Shares in major COVID-19 vaccine makers fell on Monday after an internal U.S. Food and Drug Administration (FDA) memo reportedly suggested that vaccinations may have contributed to several child deaths linked to heart infl... Full story

Yahoo Finance • 2 days ago

Faron Pharmaceuticals Ltd: Appointment of CFO

TURKU, FI / ACCESS Newswire / December 1, 2025 / Faron Pharmaceuticals Ltd. (AIM:FARN)(First North:FARON)(HEL:FARON)(LSE:FARN), a clinical-stage biopharmaceutical company, announces the appointment of Mr. Jurriaan Dekkers as the company's... Full story

Yahoo Finance • 5 days ago

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Gain 4% for Week

European equities traded in the US as American depositary receipts were trending higher late Friday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 6 days ago

Follicular Lymphoma Market Trends, Opportunities, Growth Challenges and Competitive Intelligence 2025-2035

Company Logo The global follicular lymphoma market is witnessing growth due to advancements in targeted therapies and immunotherapies. Follicular lymphoma, an indolent form of non-Hodgkin lymphoma, often presents challenges like relapse a... Full story

Yahoo Finance • 7 days ago

CMS unveils price reductions for 15 drugs for 2027

[Pills and money] txking/iStock via Getty Images Individuals covered under Medicare can expect significant savings on the 15 drugs that were selected earlier this year for drug price negotiations under the Inflation Reduction Act starting... Full story

Yahoo Finance • 7 days ago

Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied

Novo Nordisk stock jumped Wednesday on a lighter-than-feared discount for Ozempic and Wegovy under the Inflation Reduction Act. Continue Reading View Comments... Full story

Yahoo Finance • 7 days ago

IMFINZI® approved in the US as first and only perioperative immunotherapy for patients with early gastric and gastroesophageal cancers

Based on MATTERHORN Phase III trial results which showed a 29% reduction in the risk of progression, recurrence or death and a 22% reduction in the risk of death for the IMFINZI regimen vs. chemotherapy alone WILMINGTON, Del., November 26... Full story

Yahoo Finance • 7 days ago

Centers for Medicare & Medicaid Services Unveils $12 Billion Net Savings From Reduction in Drug Prices

The Centers for Medicare & Medicaid Services said Tuesday it expects to achieve net savings of 44%, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 8 days ago

AstraZeneca's Imfinzi Regimen Approved in US for Early-Stage Stomach Cancer

AstraZeneca (AZN) said Tuesday its Imfinzi in combination with standard chemotherapy was approved in PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 8 days ago

AstraZeneca's Imfinzi granted approval for gastric cancers

[Stomach Cancer - 3D Illustration] * The U.S. FDA has expanded the indication for AstraZeneca's (AZN [https://seekingalpha.com/symbol/AZN]) immunotherapy Imfinzi (durvalumab) to treat gastric and gastroesophageal junction cancers in a p... Full story

Yahoo Finance • 8 days ago

US, UK nearing drug prices deal - report

[United States of America and United Kingdom Flags. 3d Rendering] klenger/iStock via Getty Images * The US and UK governments are said to be close to a deal that would boost prices of prescription drugs in the UK in exchange for avoidin... Full story